Sawai Group Holdings Co., Ltd. (SWGHF) Research

Sawai Group Holdings Co., Ltd., along with its subsidiaries, specializes in the research, development, manufacture, and commercialization of generic pharmaceuticals, primarily serving markets in Japan and the United States. The company's extensive portfolio encompasses a variety of generic medications, available in diverse dosage forms such as tablets, capsules, injectables, and liquid formulations (including syrups, ophthalmic, and nasal solutions). These address numerous therapeutic categories, including cardiovascular, gastro-intestinal, central nervous system, metabolic, anti-infective, anti-allergic, and anti-cancer treatments, in addition to vitamin preparations. Sawai distributes its generic products through a network that includes distributors, wholesalers, and retailers across Japan and the United States. Established in 1929, the firm maintains its headquarters in Osaka, Japan.

Market snapshot

Symbol
SWGHF
Price
$11.52
Day change
0.00%
Market cap
$189.2B
P/E ratio
17.89x
52-week range
11.52-11.52
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • BioGaia AB (publ) (BIOGY)
  • China Traditional Chinese Medicine Holdings Co. Limited (CHIZF)
  • Cosmo Pharmaceuticals N.V. (CMOPF)
  • Evotec SE (EVOTF)
  • Kissei Pharmaceutical Co., Ltd. (KSPHF)
  • SSY Group Limited (LJUIF)
  • Nippon Shinyaku Co., Ltd. (NPNKF)
  • Nippon Shinyaku Co., Ltd. (NPPNY)

Open Sawai Group Holdings Co., Ltd. (SWGHF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.